Global Safety Program LeadAstraZeneca · Sweden - Gothenburg
AstraZeneca logo

AstraZeneca

company page ↗ Visa Sponsoring Company

Global Safety Program Lead

✓ This company has sponsored visas before. The posting doesn't say so, but it's still worth applying.

🗓️ Posted 2026-09-29 Sweden - Gothenburg Full-time Hybrid Healthcare Medical
💰 Salary Not shared 📊 Market 24,005 GBP–36,007 GBP/mo

About the Company

o feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Requirements

  • ● Medical degree or equivalent degree in biomedicine or science
  • ● years extensive relevant clinical, safety and risk management experience in the pharmaceutical, biotech, CRO industry, academia or Health Authorities
  • ● Proven track record of successful clinical safety delivery with demonstrated examples of strategic influence to clinical studies/programs.
  • ● Ability to collaborate across a matrixed environment and influence cross-functional- leaders on decision-making (e.g. Clinical Development, Medical Affairs, Regulatory Affairs).
  • ● Thorough knowledge and understanding of pharmacovigilance & safety deliverables, standards and processes at a global level; including pre and post launch experience.
  • ● Demonstrated ability to successfully lead, coach, and mentor other safety medical directors/scientists.
  • ● Available to travel domestically and internationally
  • ● Demonstrated ability to present complex topics to senior leaders at safety and development governances for alignment and endorsement.
  • ● PhD (or other complementary degree) in scientific discipline.
  • ● Excellent, independent judgment based on leading-edge knowledge and expertise.
  • ● Excellent speaking skills, industry conference speaking experience.
  • ● Excellent, independent judgment based on knowledge and expertise.
  • ● Demonstrated clinical safety and research expertise in an appropriate disease area.
  • ● Date Posted 29-Sept-2026
  • ● Closing Date 29-Nov-2026